Research demonstrates that metabolites from Klebsiella oxytoca under anaerobic conditions inhibit Acinetobacter baumannii, suggesting new probiotic strategies.
Multidrug-resistant (MDR) bacteria pose a significant global health threat. Among these, Acinetobacter baumannii , particularly carbapenem-resistant A. baumannii , is a leading cause of healthcare-associated infections. Emerging evidence links gut colonization to systemic infections, highlighting opportunities for new control strategies. We demonstrate that A. baumannii can survive under anaerobic conditions (≤1%) and shows limited growth under low oxygen conditions (≥1%), underscoring its adaptation to niches in the intestine. However, specific carbohydrates, including maltose, provide the gut bacteria Klebsiella oxytoca with a competitive advantage under anoxic conditions, enabling it to actively suppress A. baumannii through its metabolism. Notably, maltose induces this suppressive capacity in other commensals and complex gut microbiomes as well. Force-feeding experiments in Galleria mellonella larvae corroborate that K. oxytoca in combination with maltose significantly reduces A. baumannii recovery in gut environments. These findings suggest that targeted carbohydrate supplementation could enhance probiotic strategies, creating an environment unfavorable to A. baumannii .
No takes yet. Share an insight, caveat, or question.
Winter et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: